Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Eli Lil­ly said its rev­enues in the sec­ond quar­ter jumped 28% year-over-year due to growth from its type 2 di­a­betes drug Moun­jaro, breast can­cer treat­ment

Among other solutions, educational campaigns along with expanding access to residential rehab programs to Medicare beneficiaries could mitigate the growing trend of drug overdose deaths

Bay­er is bring­ing a Phase III tri­al for its blood thin­ner asun­dex­i­an to an ear­ly end af­ter the drug showed “in­fe­ri­or ef­fi­ca­cy” against the con­trol